Can I obtain an Octave Multiple Sclerosis Disease Activity (MSDA) test when I have only been diagnosed with transverse myelitis and do not have an ICD‑10 code for multiple sclerosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can You Get an Octave MSDA Test with Only Transverse Myelitis and No MS ICD-10 Code?

No, you should not obtain an Octave MSDA test if you have only transverse myelitis without meeting diagnostic criteria for multiple sclerosis, as this test is specifically designed to monitor disease activity in patients with an established MS diagnosis.

Understanding the Diagnostic Distinction

The critical issue here is that transverse myelitis and MS are distinct clinical entities that require careful differentiation 1. According to established diagnostic guidelines, monophasic demyelinating diseases such as acute transverse myelitis present special diagnostic challenges, and a diagnosis of MS should not be made unless new symptoms, signs, or imaging abnormalities appear more than three months after clinical onset 1.

Key Diagnostic Principles

The McDonald criteria emphasize that MS diagnosis requires:

  • Dissemination in space (lesions in multiple CNS locations)
  • Dissemination in time (evidence of disease activity at different time points)
  • Exclusion of alternative diagnoses that better explain the clinical picture 1

A single episode of transverse myelitis does not fulfill these criteria.

When Transverse Myelitis May Progress to MS

Research shows that approximately 62% of patients with acute partial transverse myelitis (APTM) eventually convert to MS 2. However, this conversion requires specific findings:

Predictive Factors for MS Conversion:

  • Oligoclonal bands in CSF (odds ratio 15.76) 2
  • At least one brain MRI lesion (odds ratio 7.74) 2
  • Brain MRI characteristics consistent with MS may predict conversion after a first partial transverse myelitis episode 3
  • Shorter spinal lesions (<3 vertebral segments) favor MS over neuromyelitis optica 3

Important Distinctions:

  • Longitudinally extensive transverse myelitis (LETM) extending over ≥3 vertebral segments suggests neuromyelitis optica spectrum disorder (NMOSD) rather than MS 4, 3
  • NMO-IgG antibodies (aquaporin-4 antibodies) should be tested to determine if transverse myelitis is due to NMOSD rather than MS 3

Clinical Algorithm for Your Situation

Step 1: Confirm Your Current Diagnosis

  • Do you have only one episode of transverse myelitis?
  • Has there been no evidence of dissemination in time or space?
  • If yes to both, you do not meet MS diagnostic criteria

Step 2: Evaluate for MS Risk Factors

Obtain the following if not already done:

  • Brain MRI to look for asymptomatic demyelinating lesions
  • CSF analysis for oligoclonal bands and IgG index
  • NMO-IgG (aquaporin-4) antibody testing to exclude NMOSD 3
  • Spinal MRI to assess lesion length and characteristics

Step 3: Determine if MS Criteria Are Met

According to the 2024 McDonald criteria 5, you need:

  • Evidence of at least 2 separate CNS lesions (dissemination in space)
  • Evidence of lesions occurring at different time points (dissemination in time)
  • No better explanation for your clinical presentation

Step 4: Regarding the Octave MSDA Test

  • This test is designed for monitoring disease activity in established MS
  • Without an MS diagnosis (and corresponding ICD-10 code G35), the test is not clinically indicated
  • Insurance coverage would likely be denied without proper diagnostic coding

Common Pitfalls to Avoid

  1. Premature MS diagnosis: Do not accept an MS diagnosis based solely on a single episode of transverse myelitis 1

  2. Missing NMOSD: Failure to test for aquaporin-4 antibodies can lead to misdiagnosis, as NMOSD requires different treatment than MS 4, 3

  3. Ignoring the 3-month rule: MS diagnosis requires that new symptoms or imaging findings appear more than 3 months after initial clinical onset 1

  4. Overlooking alternative diagnoses: Infections (HTLV1, Lyme disease), vascular disorders, and other inflammatory conditions can mimic MS 1

What You Should Do Instead

If you remain concerned about MS risk:

  • Request comprehensive workup including brain MRI, CSF analysis, and antibody testing
  • Establish regular neurological follow-up to monitor for new symptoms or lesions
  • If you develop new neurological symptoms or MRI lesions meeting dissemination criteria, then MS diagnosis becomes appropriate and the Octave MSDA test would be indicated

The bottom line: The Octave MSDA test requires an established MS diagnosis. With only transverse myelitis, you need either confirmation of MS through additional clinical/radiological evidence or continued monitoring to determine if conversion to MS occurs.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.